213 related articles for article (PubMed ID: 7957047)
21. RNA polymerase II is a glycoprotein. Modification of the COOH-terminal domain by O-GlcNAc.
Kelly WG; Dahmus ME; Hart GW
J Biol Chem; 1993 May; 268(14):10416-24. PubMed ID: 8486697
[TBL] [Abstract][Full Text] [Related]
22. Identification of a binding site in c-Ab1 tyrosine kinase for the C-terminal repeated domain of RNA polymerase II.
Baskaran R; Chiang GG; Wang JY
Mol Cell Biol; 1996 Jul; 16(7):3361-9. PubMed ID: 8668151
[TBL] [Abstract][Full Text] [Related]
23. Transcription-dependent structural changes in the C-terminal domain of mammalian RNA polymerase subunit IIa/o.
Laybourn PJ; Dahmus ME
J Biol Chem; 1989 Apr; 264(12):6693-8. PubMed ID: 2708335
[TBL] [Abstract][Full Text] [Related]
24. Requirements for RNA polymerase II carboxyl-terminal domain for activated transcription of human retroviruses human T-cell lymphotropic virus I and HIV-1.
Chun RF; Jeang KT
J Biol Chem; 1996 Nov; 271(44):27888-94. PubMed ID: 8910388
[TBL] [Abstract][Full Text] [Related]
25. Level of the RNA polymerase II in the fission yeast stays constant but phosphorylation of its carboxyl terminal domain varies depending on the phase and rate of cell growth.
Sakurai H; Ishihama A
Genes Cells; 2002 Mar; 7(3):273-84. PubMed ID: 11918671
[TBL] [Abstract][Full Text] [Related]
26. Investigating RNA polymerase II carboxyl-terminal domain (CTD) phosphorylation.
Palancade B; Bensaude O
Eur J Biochem; 2003 Oct; 270(19):3859-70. PubMed ID: 14511368
[TBL] [Abstract][Full Text] [Related]
27. The C-terminal domain-phosphorylated IIO form of RNA polymerase II is associated with the transcription repressor NC2 (Dr1/DRAP1) and is required for transcription activation in human nuclear extracts.
Castaño E; Gross P; Wang Z; Roeder RG; Oelgeschläger T
Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7184-9. PubMed ID: 10852970
[TBL] [Abstract][Full Text] [Related]
28. Tyrosine phosphorylation of RNA polymerase II carboxyl-terminal domain by the Abl-related gene product.
Baskaran R; Chiang GG; Mysliwiec T; Kruh GD; Wang JY
J Biol Chem; 1997 Jul; 272(30):18905-9. PubMed ID: 9228069
[TBL] [Abstract][Full Text] [Related]
29. A novel SR-related protein specifically interacts with the carboxy-terminal domain (CTD) of RNA polymerase II through a conserved interaction domain.
Tanner S; Stagljar I; Georgiev O; Schaffner W; Bourquin JP
Biol Chem; 1997 Jun; 378(6):565-71. PubMed ID: 9224939
[TBL] [Abstract][Full Text] [Related]
30. Identification of phosphorylation sites in the repetitive carboxyl-terminal domain of the mouse RNA polymerase II largest subunit.
Zhang J; Corden JL
J Biol Chem; 1991 Feb; 266(4):2290-6. PubMed ID: 1899239
[TBL] [Abstract][Full Text] [Related]
31. ICP22 and the UL13 protein kinase are both required for herpes simplex virus-induced modification of the large subunit of RNA polymerase II.
Long MC; Leong V; Schaffer PA; Spencer CA; Rice SA
J Virol; 1999 Jul; 73(7):5593-604. PubMed ID: 10364308
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylation of RNA polymerase II C-terminal domain and transcriptional elongation.
O'Brien T; Hardin S; Greenleaf A; Lis JT
Nature; 1994 Jul; 370(6484):75-7. PubMed ID: 8015613
[TBL] [Abstract][Full Text] [Related]
33. Yeast carboxyl-terminal domain kinase I positively and negatively regulates RNA polymerase II carboxyl-terminal domain phosphorylation.
Patturajan M; Conrad NK; Bregman DB; Corden JL
J Biol Chem; 1999 Sep; 274(39):27823-8. PubMed ID: 10488128
[TBL] [Abstract][Full Text] [Related]
34. Regulation of RNA polymerase II activity by CTD phosphorylation and cell cycle control.
Oelgeschläger T
J Cell Physiol; 2002 Feb; 190(2):160-9. PubMed ID: 11807820
[TBL] [Abstract][Full Text] [Related]
35. Inhibitors of transcription such as 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole and isoquinoline sulfonamide derivatives (H-8 and H-7) promote dephosphorylation of the carboxyl-terminal domain of RNA polymerase II largest subunit.
Dubois MF; Nguyen VT; Bellier S; Bensaude O
J Biol Chem; 1994 May; 269(18):13331-6. PubMed ID: 7513701
[TBL] [Abstract][Full Text] [Related]
36. Cdc15 Phosphorylates the C-terminal Domain of RNA Polymerase II for Transcription during Mitosis.
Singh AK; Rastogi S; Shukla H; Asalam M; Rath SK; Akhtar MS
J Biol Chem; 2017 Mar; 292(13):5507-5518. PubMed ID: 28202544
[TBL] [Abstract][Full Text] [Related]
37. Nuclear c-Abl is a COOH-terminal repeated domain (CTD)-tyrosine (CTD)-tyrosine kinase-specific for the mammalian RNA polymerase II: possible role in transcription elongation.
Baskaran R; Escobar SR; Wang JY
Cell Growth Differ; 1999 Jun; 10(6):387-96. PubMed ID: 10392900
[TBL] [Abstract][Full Text] [Related]
38. The Tat/TAR-dependent phosphorylation of RNA polymerase II C-terminal domain stimulates cotranscriptional capping of HIV-1 mRNA.
Zhou M; Deng L; Kashanchi F; Brady JN; Shatkin AJ; Kumar A
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12666-71. PubMed ID: 14569024
[TBL] [Abstract][Full Text] [Related]
39. Phosphorylation causes a conformational change in the carboxyl-terminal domain of the mouse RNA polymerase II largest subunit.
Zhang J; Corden JL
J Biol Chem; 1991 Feb; 266(4):2297-302. PubMed ID: 1989983
[TBL] [Abstract][Full Text] [Related]
40. Phosphorylation of serine 177 of the small hepatitis delta antigen regulates viral antigenomic RNA replication by interacting with the processive RNA polymerase II.
Hong SY; Chen PJ
J Virol; 2010 Feb; 84(3):1430-8. PubMed ID: 19923176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
